PAM
LJPC

Panagora Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Panagora Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,018
Closed -$4K – 2883
2021
Q2 		$4K Hold
1,018
– – ﹤0.01% 2563
2021
Q1 		$4K Hold
1,018
– – ﹤0.01% 2648
2020
Q4 		$4K Buy
+1,018
New +$4.35K ﹤0.01% 2559
2017
Q3 		– Sell
-675
Closed -$20K – 2694
2017
Q2 		$20K Buy
+675
New +$19.3K ﹤0.01% 2287
2016
Q1 		– Sell
-3,335
Closed -$90K – 2440
2015
Q4 		$90K Sell
3,335
-1,454
-30% -$39.6K ﹤0.01% 1828
2015
Q3 		$133K Sell
4,789
-24,982
-84% -$787K ﹤0.01% 1731
2015
Q2 		$730K Buy
29,771
+6,892
+30% +$142K ﹤0.01% 1218
2015
Q1 		$419K Buy
22,879
+19,606
+599% +$397K ﹤0.01% 1393
2014
Q4 		$60K Sell
3,273
-1,809
-36% -$21.5K ﹤0.01% 1996
2014
Q3 		$49K Sell
5,082
-395
-7% -$3.93K ﹤0.01% 2034
2014
Q2 		$50K Sell
5,477
-731
-12% -$6.67K ﹤0.01% 2099
2014
Q1 		$67K Buy
+6,208
New +$60.9K ﹤0.01% 2024

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Panagora Asset Management's LJPC Position: Q3 2021 in Review

Panagora Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 1,018 shares — an estimated $4K sold.

Panagora Asset Management first reported a position in LJPC in Q1 2014 and held it in 12 quarters. The position peaked at $730K in Q2 2015. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Panagora Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 1,018 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $4K.
  • Panagora Asset Management first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 12 quarters.
  • Panagora Asset Management's La Jolla Pharmaceutical Company position peaked at $730K in Q2 2015.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.